AMBULANTICUM GmbH
AMBULANTICUM GmbH operates Germany's first outpatient neurological late rehabilitation center in Herdecke, delivering interdisciplinary intensive therapy — combining physiotherapy, occupational, speech, sports, and trauma therapy with robotic and computer-assisted systems — to children and adults with stroke, spinal cord injury, TBI, MS, and Parkinson's, reimbursed mainly via statutory health insurance.
- Company typePrivate
- Founded2012
- HeadquartersHerdecke, Germany
- Headcount1–10
- GTM typeB2C
- OfferingServices
What AMBULANTICUM GmbH does
AMBULANTICUM GmbH is a German outpatient neurological late rehabilitation center founded in 2012 by Dr. Bernhard Krahl and Marion Schrimpf, headquartered in Herdecke. It operates as Germany's first and only outpatient interdisciplinary intensive therapy facility dedicated to neurological late-stage (Spät-) rehabilitation, serving children and adults with acquired neuromotor conditions including stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, Parkinson's disease, and infantile cerebral palsy. The center bundles physiotherapy, occupational therapy, speech therapy, sports/movement therapy, and trauma therapy under one roof and integrates them with robotic and computer-assisted 'Augmented Performance Feedback' systems, including the Lokomat gait robot, C-Mill instrumented treadmill, 3D Spacecurl, the CUREO virtual-reality system, and the Matrixmobil (Matrix-Rhythmus-Therapie). A proprietary 'Paten-Konzept' assigns each patient two therapists from different disciplines to coordinate the full therapy plan.
The business model is reimbursement-driven through German statutory health insurance (GKV). Patients apply to their health insurer (e.g., Techniker Krankenkasse, Barmer) for coverage of multi-week intensive therapy blocks; AMBULANTICUM holds a framework contract (Rahmenvertrag) with Techniker Krankenkasse and, since February 2024, participates with TK and CUREosity in a pilot that makes TK the first German GKV to reimburse VR therapy. Patients not covered or denied by GKV can self-pay. The GTM is sales-led and relationship-driven, relying on physician referrals, rehabilitation advisors, patient word-of-mouth, media coverage (e.g., Deutsche Hirnstiftung national campaign), and industry network memberships (MedEcon Ruhr e.V.). Distribution is exclusively direct at the single Herdecke facility; there are no resellers or indirect channels. Revenue is not publicly disclosed. The company is founder-owned and bootstrapped, with no venture or private equity investment indicated.
AMBULANTICUM GmbH firmographics
Firmographics- Name
- AMBULANTICUM GmbH
- Legal name
- AMBULANTICUM GmbH
- Website
- https://ambulanticum.de
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- AMBULANTICUM GmbH operates Germany's first outpatient neurological late rehabilitation center in Herdecke, delivering interdisciplinary intensive therapy — combining physiotherapy, occupational, speech, sports, and trauma therapy with robotic and computer-assisted systems — to children and adults with stroke, spinal cord injury, TBI, MS, and Parkinson's, reimbursed mainly via statutory health insurance.
- Ownership category
- akta.pro rank
AMBULANTICUM GmbH industry classification
Industry- Product category
- Neurological Rehabilitation Services
- NAICS
- Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Other Ambulatory Health Care Services (6219)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)
- akta.pro primary industry
- Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH)
- akta.pro secondary industries
- Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC), Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ)
Keywords
Where AMBULANTICUM GmbH is headquartered
LocationHeadquarters
- HQ city
- Herdecke
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
AMBULANTICUM GmbH business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Gesetzliche Krankenversicherung (GKV): Die Hauptfinanzierung erfolgt über die gesetzlichen Krankenkassen. Patienten beantragen Intensivtherapie bei ihrer Krankenkasse, die nach Prüfung die Therapie genehmigt. Es bestehen Rahmenverträge mit einzelnen Kassen (z.B. Techniker Krankenkasse). Da es sich um eine neue Form der Versorgung handelt, ist die Anerkennung durch die Kostenträger ein fortlaufender Prozess.
- Private Patienten / Selbstzahler: Patienten, die nicht über die gesetzliche Krankenversicherung abgedeckt sind oder deren Kassen die Therapie nicht genehmigen, können als Selbstzahler die Intensivtherapie in Anspruch nehmen.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Intensivtherapie für neurologische Patienten (Kinder und Erwachsene) |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels8 records
AMBULANTICUM GmbH product offering
Product offeringCore offering
AMBULANTICUM delivers outpatient interdisciplinary intensive therapy for children and adults with neurological conditions such as stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, Parkinson's disease, and infantile cerebral palsy. The offering combines traditional therapies (physiotherapy, occupational therapy, speech therapy, sports therapy, trauma therapy) with state-of-the-art robotic and computer-assisted Augmented Performance Feedback therapies (Lokomat, C-Mill, CUREO VR, Spacecurl 3D) under one roof. Each patient receives an individualized multi-week intensive therapy program coordinated by two dedicated therapist 'patrons' (Paten-Konzept).
Product overview
AMBULANTICUM is an outpatient interdisciplinary intensive therapy center for neurological diseases offering a unified treatment approach that combines traditional therapies (Physiotherapy, Occupational Therapy, Speech Therapy, Sports Therapy, Trauma Therapy) with modern robotic and computer-aided Augmented Performance Feedback therapies under one roof. The core offering is intensive rehabilitation for children and adults with acquired neuromotor diseases including stroke, spinal cord injuries, traumatic brain injuries, cerebral palsy, multiple sclerosis, and Parkinson's disease.
Differentiator
Problem solved
Functional benefit
Products and services
- Ambulanticum Intensivtherapie Intensive interdisciplinary therapy program combining physiotherapy, occupational therapy, sports therapy, speech therapy, and trauma therapy with modern robotic and computer-aided Augmented Performance Feedback therapies for children and adults with acquired neurological diseases in late-stage rehabilitation.
- Robotik- und gerätegestützte Therapie Robot-assisted and computer-aided therapy service using state-of-the-art equipment including the Lokomat gait robot, C-Mill treadmill with Augmented Performance Feedback, CUREO VR therapy, and other therapeutic devices for intensive neurological rehabilitation.
- Physiotherapie Physical therapy services delivered as part of the interdisciplinary treatment approach for neurological patients at the Ambulanticum center.
- Ergotherapie Occupational therapy services integrated into the comprehensive neurological rehabilitation program for children and adults.
- Logopädie Speech and language therapy for patients with neurological conditions affecting communication and swallowing.
- Sport- und Bewegungstherapie Sports and movement therapy service delivered as part of the holistic neurological rehabilitation approach.
- Traumatherapie Trauma therapy services for patients with trauma-related conditions, integrated into the interdisciplinary neurological rehabilitation program.
- CUREO VR Therapy System Virtual-reality therapy system providing cognitive and sensomotor training through immersive visual environments, integrated as a therapy component in the Ambulanticum program through a pilot partnership with Techniker Krankenkasse and CUREosity.
Quantifiable outcome
- 2000+ patients treated since founding in 2012
- +2 more outcomes
Companies that use AMBULANTICUM GmbH
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles1 record
AMBULANTICUM GmbH technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature10 records
AMBULANTICUM GmbH partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- FernUniversität HagencoreAMBULANTICUM and FernUniversität Hagen (both MedEcon Ruhr members) have agreed to collaborate on networking research, teaching, and practice. Prof. Dr. Jenny Sarah Wesche and Dr. Christina Weckwerth from the psychology faculty visited the center and were impressed by the holistic therapy approach, interdisciplinary team, and state-of-the-art robotic/computer-assisted treatment options. The collaboration aims to connect science and practice for the development of modern therapies.
- Stiftung Deutsche Schlaganfall-HilfeminorDeutsche Schlaganfall-Hilfe visited Ambulanticum in Herdecke. Stifterin Liz Mohn, Kuratoriums-Vorsitzende Dr. Brigitte Mohn, and stellvertretende Vorstandsvorsitzende Sylvia Strothotte were impressed by the holistic therapy concept, interdisciplinary team competence, and robotic/computer-assisted therapy. The foundation shares the goal of optimally supporting neuromotorically ill people (e.g., stroke patients) on their path back to independent life.
- Techniker Krankenkasse (TK)coreTechniker Krankenkasse and Ambulanticum, together with Med-Tech company CUREosity, are part of a joint pilot project for Virtual-Reality therapy (VR). TK is the first statutory health insurer in Germany to reimburse VR therapy. The one-year pilot evaluates patient motivation and feasibility of the CUREO VR therapy system in daily therapy. TK has a framework contract (Rahmenvertrag) with Ambulanticum.
- CUREositycoreMed-Tech company CUREosity provides the CUREO VR therapy system for the joint pilot project with Ambulanticum and Techniker Krankenkasse. CUREO is used as a new component in Ambulanticum's holistic therapy concept for cognitive and sensomotor VR therapy.
- Deutsche HirnstiftungminorAmbulanticum patient Linus Basch was featured in Deutsche Hirnstiftung's first national information campaign, which covers three major neurological topic areas: migraine, stroke, and traumatic brain injury. The campaign highlights that even with serious neurological diseases, living a normal life is possible with modern therapies.
- Herdecker Kanu-Club 1925 e.V.minorAmbulanticum organized a two-day seminar on 'Inclusion in Paddle Sports' in cooperation with Herdecker Kanu-Club 1925 e.V. and the German Canoe Association (DKV). The event introduced adaptive water sports for people with and without disabilities. Therapeutic paddling is planned as a future therapy offering for Ambulanticum patients, training balance and trunk stability.
- Körber-StiftungminorKörber-Stiftung awarded Dr. Bernhard Krahl the Zugabe-Preis 2020 and produced a portrait film about him at the Ambulanticum facility. The foundation recognizes individuals who have made outstanding contributions to society after overcoming significant challenges.
- MedEcon Ruhr e.V.minorAMBULANTICUM has been a member of MedEcon Ruhr e.V. since February 2012. MedEcon Ruhr is an association of companies and institutions from the health economy in the Ruhr metropolitan region, operating across municipal boundaries and connecting various sectors in healthcare.
- Universität Witten/HerdeckeminorUniversity of Witten/Herdecke supports AMBULANTICUM through a collaborative partnership for scientific research projects. Prof. Dr. Neugebauer (Chair of Surgical Research) offered to serve as a partner for research projects in the context of healthcare research.
- Stadt HerdeckeminorThe city of Herdecke welcomed the establishment of Ambulanticum, recognizing it as an excellent fit for the local medical landscape. The economic development office supports the center's establishment and concept implementation.
- EN-Agentur (Wirtschaftsförderungsagentur Ennepe-Ruhr)minorThe EN-Agentur (Ennepe-Ruhr economic development agency) welcomed the founding of Ambulanticum, noting the region's high density of clinical care and strengths in rehabilitation and integrative medicine. The agency supports the initiative within its possibilities.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
AMBULANTICUM GmbH competitors and assessment
Company assessmentDirect peers
- Medical Park: Major German private rehabilitation hospital group with strong neurological and orthopedic rehab programs. Cited in an Ambulanticum customer testimonial, indicating direct market overlap in physician referral networks.
- MEDICLIN: Germany-wide operator of rehabilitation clinics and hospitals, including neurological rehab. Comparable in providing multi-disciplinary neuro-rehab but with a primarily inpatient delivery model.
- St. Mauritius Therapieklinik: Specialized neurological rehabilitation clinic in Meerbusch, Germany. Closest direct competitor in the inpatient neurological rehab segment with comparable patient populations (stroke, TBI, MS).
- Kliniken Schmieder: Germany's largest group of neurological rehabilitation clinics, with multiple inpatient and day-clinic sites. Directly comparable as a specialized neurological rehabilitation provider, although Schmieder operates at significantly larger scale and primarily in inpatient settings.
- Median Kliniken: One of the largest German rehabilitation clinic operators with neurological and orthopedic focus. Comparable in clinical scope but operates at much larger inpatient scale.
Others
- CUREosity: Med-tech company behind the CUREO VR therapy system used in Ambulanticum's TK pilot. Comparable as a technology partner/ecosystem participant rather than a direct clinical competitor.
Broad incumbents
- Helios Kliniken: One of Germany's largest private hospital groups, with post-acute and rehabilitation services. Comparable as a broad healthcare incumbent that could expand into intensive outpatient neuro-rehab.
- Asklepios Kliniken: Large German private hospital operator with rehabilitation facilities. Comparable as a broad incumbent with adjacent rehab capabilities but not specialized in late neurological outpatient rehab.
- Schön Klinik: Major German private hospital group with strong neurology and orthopedic rehabilitation programs. Comparable as a broader neuro/ortho rehab incumbent.
Emerging players
- RehaNova Köln: Outpatient neurological rehabilitation center in Cologne. Comparable as an emerging specialized outpatient neuro-rehab provider, though smaller in scale and without robotics-assisted therapy breadth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
AMBULANTICUM GmbH social profiles
Digital presenceAMBULANTICUM GmbH financial estimates
Financial estimateRevenue estimate
Valuation estimate
AMBULANTICUM GmbH leadership team
Management profileNumber of profiles
Profiles2 records
AMBULANTICUM GmbH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AMBULANTICUM GmbH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AMBULANTICUM GmbH
What does AMBULANTICUM GmbH do?
AMBULANTICUM delivers outpatient interdisciplinary intensive therapy for children and adults with neurological conditions such as stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, Parkinson's disease, and infantile cerebral palsy. The offering combines traditional therapies (physiotherapy, occupational therapy, speech therapy, sports therapy, trauma therapy) with state-of-the-art robotic and computer-assisted Augmented Performance Feedback therapies (Lokomat, C-Mill, CUREO VR, Spacecurl 3D) under one roof. Each patient receives an individualized multi-week intensive therapy program coordinated by two dedicated therapist 'patrons' (Paten-Konzept).
Is AMBULANTICUM GmbH a public or private company?
AMBULANTICUM GmbH is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AMBULANTICUM GmbH founded?
AMBULANTICUM GmbH was founded in 2012. It employs 1 to 10 people.
Where is AMBULANTICUM GmbH based?
AMBULANTICUM GmbH is headquartered in Herdecke, Germany, in the Europe region.
How does AMBULANTICUM GmbH make money?
Two revenue lines are on record. Gesetzliche Krankenversicherung (GKV) is the primary driver. The others are private Patienten / Selbstzahler.
Who are AMBULANTICUM GmbH's main competitors?
Direct peers on record are Medical Park, MEDICLIN, St. Mauritius Therapieklinik, Kliniken Schmieder and Median Kliniken. CUREosity is listed as an others. Broad incumbents are Helios Kliniken, Asklepios Kliniken and Schön Klinik. RehaNova Köln is listed as an emerging player.
Does AMBULANTICUM GmbH have an API?
No public API is recorded for AMBULANTICUM GmbH.
What industry is AMBULANTICUM GmbH in?
AMBULANTICUM GmbH's product category is Neurological Rehabilitation Services. Its primary akta.pro industry code is HLADAJAH, Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s), with a secondary code of HSADAIAC, Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS). Its NAICS code is 62134 and its SIC code is 8093.